Focused on developing therapies for rare genetic diseases, this biotechnology company markets several enzyme replacement and other treatments targeting small patient populations with high unmet medical need. Its portfolio includes approved drugs for conditions such as achondroplasia and lysosomal st...
10 members of Congress have disclosed 24 trades in BioMarin Pharmaceutical Inc. (BMRN), a Healthcare company. The buy/sell breakdown shows 11 purchases versus 13 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-03-14 | Rohit Khanna | sell | $1K – $15K |
| 2023-03-06 | Daniel Goldman | sell | $1K – $15K |
| 2022-05-04 | Rohit Khanna | buy | $1K – $15K |
| 2021-10-18 | Josh Gottheimer | sell | $1K – $15K |
| 2020-12-30 | Gilbert Cisneros | buy | $15K – $50K |
| 2020-10-16 | Josh Gottheimer | buy | $1K – $15K |
| 2020-09-15 | Josh Gottheimer | sell | $1K – $15K |
| 2019-12-16 | Josh Gottheimer | buy | $1K – $15K |
| 2019-12-11 | Josh Gottheimer | buy | $1K – $15K |
| 2019-08-15 | ALAN S. LOWENTHAL | sell | $1K – $15K |
| 2019-08-15 | ALAN S. LOWENTHAL | sell | $506+ |
| 2019-08-14 | ALAN S. LOWENTHAL | sell | $1K – $15K |
| 2019-08-14 | ALAN S. LOWENTHAL | sell | $217+ |
| 2019-03-25 | Nicholas Van Taylor | sell | $1K – $15K |
| 2018-05-29 | ALAN S. LOWENTHAL | buy | $903+ |
| 2018-04-27 | ALAN S. LOWENTHAL | buy | $1K – $15K |
| 2018-04-26 | ALAN S. LOWENTHAL | buy | $1K – $15K |
| 2018-02-12 | Lamar Smith | sell | $1K – $15K |
| 2018-01-18 | ALAN S. LOWENTHAL | buy | $1K – $15K |
| 2018-01-17 | ALAN S. LOWENTHAL | buy | $1K – $15K |
| 2017-11-09 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2016-09-12 | K. Michael Conaway | sell | $1K – $15K |
| 2015-01-27 | Thomas MacArthur | sell | $1K – $15K |
| 2014-11-14 | Lamar Smith | buy | $1K – $15K |